On 'This Week in Pharmacy' we're talking about the "Fully Powered Event" with Dr. Christina Fontana, we jump into TWIRx News with Andy Crawford from Keysource, preparing for the NASP 2025 in Denver & welcome the Rated Rx Podcast to the PPN! TWIRx News includes: Massachusetts governor orders pharmacies to make COVID shots accessible - from CBS News Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership - from AOL Finance The oldest pharmacy in Texas closes after 153 years - from DeWitt County Today This episode is sponsored by Keysource and Sykes & Company, thank you for supporting the only weekly news podcast in pharmacy, this is TWIRx!!

In this episode, we sit down with the President of the American Medical Association to discuss PBM reform and its impact on patients, physicians, and the future of healthcare. From drug pricing transparency to ensuring access to needed medications, this conversation explores why PBM reform is at the center of today’s healthcare policy debates.

In this final part of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025.

Our guests are:

• Jon Carlson at Outcomes
• Pharmacist Heidi Polek, Vice President of Product Management at Outcomes
• Multi-location Pharmacy Owner, and Pharmacy 50 Award winner Dr. Chris Antipas
• Product Manager at Outcomes, Dalia Rios
• Paul Shelton
• Tim Cernohous, Senior Vice President of Community Retail and Long term care Pharmacy at Cencora.

This episode is sponsored by Outcomes.

Join our co-hosts Todd Eury and Greg Reybold in this exclusive interview with Conor Sheehey, who most recently served as senior health policy advisor to U.S. Senate Finance Committee Chair Mike Crapo (R-ID). In this role, he advised the Committee on a range of health care policy issues, including prescription drug pricing, telehealth, AI, provider coverage and reimbursement, fraud and abuse, medical devices, and Medicare Parts B and D. Sheehey led several bipartisan legislative efforts, including the development of comprehensive PBM reforms and bipartisan proposals on clinician payment reform and drug shortages.

Psilocybin has demonstrated a long track record of safety and efficacy in a variety of conditions including depression, anxiety, addiction, trauma, and cognitive decline. Although to date, this natural substance remains classified as a Schedule 1 drug, there are protected use scenarios including sincere spiritual use. The Religious Freedom Restoration (RFRA) act lies at the foundation of Setas Seminary's protected use of psilocybin sacrament. With a background in biology, Pam Conboy was trained as a clinical laboratorian and is currently a doctoral student in naturopathic medicine. She is an IIN certified health coach, trained psychedelic facilitator, medical marketing|business development entrepreneur, and ordained minister. With a background in biochemistry and emergency medicine, Leah Linder is a naturopathic physician trained in psychedelic assisted therapy with deep expertise in natural supplement formulation and manufacture. She is a Master Gardener, experienced educator, and ordained minister. Check out the episode and links below for tons of psychedelic learning resources mentioned, and giving a shout out to the Psychedelic Pharmacists Association (PPA) - an excellent first step for fellow pharmacists. Connect with Pam Conboy and Setas Seminary via: Email: pamconboy@setasseminary.org Website: Setas Seminary IG: @setas.seminary Linked In: Pam Conboy Mushroom Magic Ebook: https://drive.google.com/file/d/19wY94Rdk64-Q9QR5M-HbQp4XP2HjB5Ov/view?usp=sharing

Welcome (back) to the Opioidology podcast series! Next up to bat, ‘Opioid Selection”. What’s YOUR “Go To Opioid”??? No really, pick a given patient scenario, as respectively there’s many, and what is your “Go To Opioid” when a prescription opioid is warranted??? Pain Guy posed this question on LinkedIn over a year ago, and society failed (as in succumbed to the Opioidphobia culture). So join us in this episode to take a methodical journey distinguishing prescription opioids to once and for (almost) all, be able to have our ducks in a row for opioid selection. Listen in to this Pain Pod episode for an unbiased, in your face, here’s how it is approach to explaining opioid selection (beyond the “To Opioid or Not to Opioid” debate). Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

In part two of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025.

Our guests are:

• Kris Rhea with Pharmacy Market Place
• Outcomes Director of Product Management, Matt Kiethanom
• Bonnie Bond with Sykes and Company Accounting
• Vice President of Product Management at Outcomes, Dr. Heidi Polek and Kunal Vyas, CEO of RxMile
• CEO of the Alliance for Pharmacy Compounding, Scott Brunner
• Dr. Mark Amoo with Outcomes

This episode is sponsored by Outcomes.